Portfolio

Cancer screening & liquid biopsy based on EVs and exosomes

Cancer screening & liquid biopsy based on EVs and exosomes

 

WE ARE A DISTRIBUTING PARTNER OF exosomics 

 

Exosomics offers a wide range of proprietary solutions for cancer screening and liquid biopsy, suitable for research use and clinical diagnostics. Exosomics’ mission is to develop and commercialize a new generation of tests for cancer screening and liquid biopsy, based on analysis of circulating extracellular vesicles and exosomes. Exosomics envisions a world in which a simple blood draw will be sufficient for early diagnosis, easier monitoring and ultimately better patient outcomes.

EARLY – RELEVANT – NON-INVASIVE – AFFORDABLE

 


PRODUCT CATEGORIES  

Pre-Analytical Solutions allow selective isolation of tumour-derived exosomes and extraction of DNA or RNA through peptide-affinity or antibody-affinity methods, respectively.

ExoRef are exosomes containing cancer relevant mutations at a verified allelic frequency in an anhydrous format. ExoRef standards allow the standardization of pre-analytical and analytical procedures involving the analysis of exosome content

LB-SeleCTEV™ kit line couples SeleCTEV™ DNA Enrichment Kit with analytical assays to overall improve the detection of clinically relevant targets.


SERVICES


RESOURCES


ANOPOLI'S TOPSELLERS


  

Feel free to order now via our contact form to see how our products work for you!

  

Date

11 March 2019

Tags

Diagnostics and Clinical Research, Discovery and Translational Research